JAK-STAT Signaling Enables Lineage Plasticity-driven AR Targeted Therapy Resistance
S. Deng, C. Wang, Y. Wang, Y. Xu, X. Li, N. Johnson, U.-G. Lo, L. Xu, J. Gonzalez, L. Metang, J. Ye, C. R. Tirado, K. Rodarte, Z. Xie, C. Arana, , P. Mu
The paper identifies JAK-STAT signaling as a key driver of lineage plasticity-driven resistance to AR targeted therapy in prostate cancer using integrated transcriptomic and scRNA-Seq analysis.
bioRxiv · Nov 2, 2021Cancer Biology